Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 83 citing Yamaoka: Efficacy of lifestyle education to prevent type 2 diabetes. (0.11 sec) 

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: …

- diabetesmidt.dk [PDF] 
J Lindström, P Ilanne-Parikka, M Peltonen, S Aunola, … - The Lancet, 2006 - Elsevier
During the total follow-up, the incidence of type 2 diabetes was 4·3 and 7·4 per 100 person-years
in the intervention and control group, respectively (log-rank test p=0·0001), indicating 43% reduction
in relative risk. The risk reduction was related to the success in achieving the intervention ...
Cited by 239 - Related articles - BL Direct - All 11 versions

Genetic variations in PPARD and PPARGC1A determine mitochondrial function …

- endojournals.org
N Stefan, C Thamer, H Staiger, F Machicao, J … - Journal of Clinical …, 2007 - Endocrine Soc
Results: After 9 months of intervention, the minor G allele of SNP rs2267668 in PPARD and the
minor serine-encoding allele of the common Gly482Ser SNP in PPARGC1A were independently
associated with less increase in individual anaerobic threshold (n = 136, P = 0.002 and P ...
Cited by 24 - Related articles - BL Direct - All 4 versions

Inflammation in metabolic syndrome and type 2 diabetes: Impact of dietary glucose


K KEMPF, B ROSE, C HERDER, U … - Annals of the New …, 2006 - ingentaconnect.com
Chronic overnutrition combined with a lack of exercise is the main cause for the rapidly increasing
prevalence of overweight and obesity. It seems accepted that adipositis (macrophage infiltration
and inflammation of adipose tissue in obesity) and systemic low grade inflammation affect ...
Cited by 22 - Related articles - BL Direct - All 4 versions

[PDF] Pharmacologic and nonpharmacologic strategies for weight gain and metabolic …


G Faulkner, TA Cohn - Canadian Journal of Psychiatry, 2006 - ww1.cpa-apc.org
Page 1. In Review Pharmacologic and Nonpharmacologic Strategies for Weight Gain
and Metabolic Disturbance in Patients Treated With Antipsychotic Medications Guy
Faulkner, BEd, MSc, PhD 1 , Tony A Cohn, MB, ChB, MSc, FRCPC 2 ...
Cited by 18 - Related articles - View as HTML - BL Direct - All 8 versions

A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet …


S Lindeberg, T Jönsson, Y Granfeldt, E Borgstrand, J … - Diabetologia, 2007 - Springer
Abstract Aims/hypothesis Most studies of diet in glucose intolerance and type 2 diabetes have
focused on intakes of fat, carbo- hydrate, fibre, fruits and vegetables. Instead, we aimed to compare
diets that were available during human evolution with more recently introduced ones. ...
Cited by 18 - Related articles - BL Direct - All 4 versions

Enabling health systems transformation: what progress has been made in re- …


M Wise, D Nutbeam - Promotion and Education, 2007 - ped.sagepub.com
The Ottawa Charter has been remark- ably influential in guiding the development of the goals
and concepts of health promo- tion, and in shaping public health practice in the past 20
years. The magnitude of the impact belies the fact that the Ottawa Char- ter was ...
Cited by 13 - Related articles - BL Direct - All 4 versions

Primary prevention of cardiovascular disease and type 2 diabetes in patients at …

- endojournals.org
JL Rosenzweig, E Ferrannini, SM Grundy, SM … - Journal of Clinical …, 2008 - Endocrine Soc
Conclusions: Healthcare providers should incorporate into their practice concrete measures
to reduce the risk of developing CVD and T2DM. These include the regular screening and identification
of patients at metabolic risk (at higher risk for both CVD and T2DM) with measurement of ...
Cited by 12 - Related articles - All 5 versions

Acarbose: oral antidiabetes drug with additional cardiovascular benefits


M Hanefeld, F Schaper - Expert Review of Cardiovascular Therapy, 2008 - ingentaconnect.com
Acarbose is an α-glucosidase inhibitor acting specifically at the level of postprandial glucose
excursion. This compound lowers HbA1c by 0.5–1% in patients with Type 2 diabetes, either drug
naive or in combination with other antidiabetic drugs. In those with impaired glucose ...
Cited by 11 - Related articles - All 5 versions

Project HEAL: peer education leads to weight loss in Harlem

- jhu.edu [PDF] 
JZ Goldfinger, G Arniella, J Wylie-Rosett, CR … - Journal of Health Care …, 2008 - muse.jhu.edu
Abstract: Background. Obesity and diabetes are epidemic in the predominantly minority Harlem
community. To address them, a coalition of community and academic leaders tested the effectiveness
of a peer-led weight loss course. Methods. The coalition developed Project HEAL: ...
Cited by 8 - Related articles - BL Direct - All 4 versions

Prevention of type 2 diabetes in a primary health care setting Interim results from …


A Kilkkinen, S Heistaro, T Laatikainen, E Janus, A … - Diabetes research and …, 2007 - Elsevier
Although clinical trials have shown that lifestyle modifications reduce the risk of type 2
diabetes, translating lessons from trials to primary care remains a challenge. The aim of the study
was to evaluate efficacy and feasibility of primary care-based diabetes prevention model ...
Cited by 7 - Related articles - All 10 versions


Result Page: 

1

2

3

4

5

6

7

8

9

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google